Tech Company Financing Transactions
AGI Dermatics Funding Round
On 4/8/2008, AGI Dermatics raised $5 million in funding from Spring Mountain Capital and Trevi Health Ventures.
Transaction Overview
Company Name
Announced On
4/8/2008
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Spring Mountain Capital (Lead Investor)
Trevi Health Ventures (Lead Investor) (Andrew Fink)
Proceeds Purpose
The new capital is being used to fund the continued growth of the Remergent brand skincare, including the launch of four new products. The Remergent skincare line preserves and restores healthy skin utilizing DNA repair enzymes delivered to the skin through a proprietary liposome delivery system.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
205 Buffalo Ave.
Freeport, NY 11520
USA
Freeport, NY 11520
USA
Phone
Website
Email Address
Overview
The passion at AGI Dermatics is skin photobiology, which is the study of biological effects of sunlight on skin. Within this field, we are dedicated to research on DNA repair, solar impact on the immune system, photoaging, tanning, and cell-signaling in skin.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Daniel Yarosh
Chief Financial Officer
Robert Nostrand
Chief Operating Officer
Jonathan Klein
Browse more venture capital transactions:
Prev: 4/7/2008: Covestor venture capital transaction
Next: 4/8/2008: Marin Software venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs